Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

NCT02705612 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Cisplatin
RADIATION: External Beam Radiation Therapy
RADIATION: Internal Radiation Therapy
DRUG: nimotuzumab

Sponsor

Air Force Military Medical University, China